Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04HVB
|
||||
| Former ID |
DIB016001
|
||||
| Drug Name |
Panomifene
|
||||
| Synonyms |
Panomifine; EGIS-5650
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Discontinued in Phase 2 | [545192] | ||
| Company |
EGIS Gyogyszergyar RT
|
||||
| Formula |
C25H24F3NO2
|
||||
| Canonical SMILES |
C(=C(\c1ccc(cc1)OCCNCCO)/c1ccccc1)(/C(F)(F)F)\c1ccccc1
|
||||
| CAS Number |
CAS 77599-17-8
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Modulator | [534524] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.